Skip to main content

Table 2 Core and surrogate Maternal and Neonatal Tetanus Elimination (MNTE) sustainability indicators, platforms for introducing Tetanus Toxoid-Containing Vaccines (TTCV) booster doses, and Gavi eligibility status in the 28 countries that were validated for MNTE elimination during 2011–2020

From: Sustaining Maternal and Neonatal Tetanus Elimination (MNTE) in countries that have been validated for elimination – progress and challenges

Country Year validated for MNTE   MNTE sustainability indicators TTCV booster dose in national vaccination schedules TTCV booster platforms Gavi support [16]
DTP3 [11] TTCV2 + [11] PAB [12] ANC1 [13, 14] ANC4 [13, 14] HFD [13, 14] SBA [13, 14] 1st booster [11] 2nd booster, [11] 3rd booster [11] SVP exists [11] MCV2 Intro [11] HPV Intro [11]  
Burkina Faso 2012 91% 69% 95% ND ND ND ND No No No No Yes No Yes
Cambodia 2015 92% 77% 95% 95% 79% 83% 89% No No No No Yes No Yes
Cameroon 2012 69% 62% 83% 87% 65% 65% 69% No No No No No No Yes
Chad 2019 52% 74% 78% ND ND ND ND No No No No No No Yes
China 2012 99% ND ND ND ND ND ND Yes Yes No No Yes No No
Cote d'Ivoire 2013 80% 75% 86% ND ND ND ND No No No Yes No Yes Yes
DRC 2019 57% 96% 85% ND ND ND ND No No No No No No Yes
E/Guinea 2015 53% 36% 60% ND ND ND ND No No No No No No No
Ethiopia 2017 71% 90% 90% 74% 43% 48% 50% No No No Yes Yes Yes Yes
Gabon 2013 63% 43% 83% ND ND ND ND No No No No No No No
Ghana 2011 94% 62% 90% 98% 89% 79% 79% No No No No Yes No Yes
G/Bissau 2012 74% 44% 83% ND ND ND ND No No No No No No Yes
Haiti 2016 51% 44% 80% 91% 67% 39% 42% Yes No No No Yes No Yes
India 2015 91% 78% 90% 79% 51% 79% 81% Yes Yes No No Yes No Yes
Indonesia 2016 77% 54% 85% 98% 77% 74% 91% Yes Yes Yes Yes Yes Yes No
Iraq 2013 74% 42% 73% ND ND ND ND Yes Yes No No Yes No No
Kenya 2018 89% ND 88% ND ND ND ND No No No No Yes Yes Yes
Lao PDR 2013 79% 43% 93% ND ND ND ND No No No No Yes No Yes
Liberia 2011 65% 20% 90% 98% 87% 80% 84% No No No No Yes Yes Yes
Madagascar 2014 68% 52% 75% ND ND ND ND No No No No No No Yes
Mauritania 2015 71% 31% 83% 85% 38% 70% 72% No No No No No No Yes
Niger 2016 81% 71% 83% ND ND ND ND No No No No Yes No Yes
Philippines 2015 71% 39% 91% 94% 87% 78% 84% No No No Yes Yes No No
Senegal 2011 91% 68% 95% 98% 56% 80% 74% No No No Yes Yes Yes Yes
Sierra Leone 2013 91% 95% 93% 98% 79% 83% 87% No No No No Yes No Yes
Tanzania 2012 86% 100% 91% 98% 51% 63% 64% No No No Yes Yes Yes Yes
Timor–Leste 2012 86% 34% 83% 84% 77% 49% 57% Yes Yes No Yes Yes No Yes
Uganda 2011 89% 65% 83% 97% 60% 73% 74% No No No Yes No Yes Yes
  1. E/Guinea Equatorial Guinea, G/Bissau Guinea Bissau, Lao PDR Lao People’s Democratic Republic, MNTE maternal and neonatal tetanus elimination, TTCV tetanus toxoid containing-vaccines, TTCV2 + at least two doses of tetanus toxoid containing-vaccines, DTP3 third dose of diphtheria-tetanus-pertussis vaccine, PAB protection at birth against tetanus, ANC1 one antenatal care visit, ANC4 four antenatal care visits, HFD health facility delivery, SBA skilled birth attendance, SVP school vaccination program, MCV2 intro introduction of second dose of measles containing vaccines, HPV intro introduction of human papillomavirus vaccine, Gavi Gavi, the Vaccine Alliance ND No data